Cigna’s Evernorth caps weight-loss drug copays at $200/month
Contributor since / Followers
aprott
Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs – Wegovy from Novo Nordisk (NVO) and Eli Lilly’s (NYSE:LLY) Zepbound.
The monthly copay for GLP-1 weight loss medicines will be limited to no more than $200 under the new offering. Patients can save as much as $3,600 per year compared to buying these medications directly from manufacturers or through consumer programs.
The reduced pricing is the result of direct negotiations between Evernorth and the drugs’ manufacturers.
Wegovy has a list price of $1,349.02/package, while Zepbound comes at a list price of $1,086.37 per fill. However, the amount a patient pays largely depends on their prescription drug insurance plan.
Source: Press Release